Literature DB >> 4886120

Combination chemotherapy in lymphosarcoma and reticulum cell sarcoma.

B Hoogstraten, A H Owens, R E Lenhard, O J Glidewell, L A Leone, K B Olson, J B Harley, S R Townsend, S Miller, C L Spurr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4886120

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

1.  Therapy of advanced lymphocytic lymphoma a preliminary report of a randomized trial between combination chemotherapy (CVP) and intensive radiotherapy.

Authors:  G P Canellos; V T DeVita; R C Young; B A Chabner; P S Schein; R E Johnson
Journal:  Br J Cancer Suppl       Date:  1975-03

2.  Non-Hodgkin's lymphoma in Ibadan, Nigeria.

Authors:  O A Oluboyede; W A Olaofe; G J Esan
Journal:  J Natl Med Assoc       Date:  1977-07       Impact factor: 1.798

3.  Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type.

Authors:  T A Lister; M H Cullen; M E Beard; R L Brearley; J M Whitehouse; P F Wrigley; A G Stansfeld; S B Sutcliffe; J S Malpas; D Crowther
Journal:  Br Med J       Date:  1978-03-04

4.  New agents and combination chemotherapy of non-Hodgkin's lymphoma.

Authors:  A T Skarin; E Frei; W C Moloney; J U Gutterman
Journal:  Br J Cancer Suppl       Date:  1975-03

5.  Intermittent combination chemotherapy with chlorambucil and prednisone of low-grade malignant non-Hodgkin's lymphomas according to the Kiel classification.

Authors:  G Stolzenbach; M Garbrecht
Journal:  J Cancer Res Clin Oncol       Date:  1979-02-19       Impact factor: 4.553

6.  Neurological toxicity of vindesine used in combination chemotherapy of 51 human solid tumors.

Authors:  C Focan; R Olivier; S Le Hung; R Bays; J J Claessens; H Debruyne
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

Review 7.  The management of follicular lymphoma.

Authors:  A Z Rohatiner; T A Lister
Journal:  Drugs       Date:  1994       Impact factor: 9.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.